Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Merck and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer
2018-11-19 22:45
Patient Blood Management presented to the U.S.-China Health Summit by IFPBM
2018-11-19 20:53
Bridge Biotherapeutics Files Investigational New Drug Application for BBT-877, an Autotaxin Inhibitor for Idiopathic Pulmonary Fibrosis
2018-11-19 07:00
World Institute of Kimchi: Function-enhanced kimchi inhibits growth of cancer cells
2018-11-16 22:00
WuXi AppTec Opens Its New Medical Device Testing Center in Suzhou
2018-11-16 18:00
Cedrus Investments Hosted Life Sciences Forum and Dinner
2018-11-16 09:00
MorphoSys and I-Mab Sign Strategic Partnering Agreement for MorphoSys's Novel Immuno-Oncology Agent MOR210
2018-11-16 05:01
TWi Biotechnology, Inc. Announces Last Patient Enrolled in Phase 2 Study of AC-201CR for Treatment of Hemophilic Arthropathy
2018-11-15 17:16
Sanofi holds China Health Road Symposium at CIIE
2018-11-14 11:20
F1 Oncology's International Affiliate, EXUMA Biotechnology, Announces Acquisition Of Strategic CAR-T Assets
2018-11-13 22:00
Esco Medical secures CFDA approval on the MIRI(R) TL and MIRI(R) Embryo Incubators
2018-11-13 10:00
NMPA Accepts Biosimilar New Drug Application for IBI303, a Biosimilar Candidate to Humira(R) (adalimumab)
2018-11-13 08:00
Angion Biomedica and Sinovant Sciences Enter into Collaboration and License Agreement to Develop BB3 in Greater China
2018-11-13 05:30
Johnson & Johnson Asia Pacific Regional Counsel Eric Wu Returns to Ropes & Gray in Shanghai
2018-11-13 03:16
The First Pellino-1 Inhibitor BBT-401 Confirms Its Safety and Tolerability from the Phase I Study
2018-11-12 16:00
Ascletis Appoints Dr. Lindi Tan as Chief Financial Officer
2018-11-12 07:30
Head of Global Patient Access Joins Inceptua
2018-11-09 18:40
Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with First-line Squamous NSCLC at Asia Conference on Lung Cancer 2018
2018-11-09 15:18
Berry Genomics and Prenetics Establish JV to Enter China's Consumer Genetics Market
2018-11-09 00:22
Sinovac Reports Unaudited First Half of 2018 Financial Results
2018-11-08 20:00
1
316
317
318
319
320
440